CD9 Antikörper
(1 reference)-
- Target Alle CD9 Antikörper anzeigen
- CD9
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD9 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS)
- Spezifität
- Human/Hamster/Canine/Feline/Monkey/Rabbit/Raccoon CD9, Mr 24 kDa
- Produktmerkmale
- Mouse Anti-Human CD9-UNLB
- Aufreinigung
- Purified
- Immunogen
- Unknown
- Klon
- MM2-57
- Isotyp
- IgG2b
- Top Product
- Discover our top product CD9 Primärantikörper
-
anti-CD9 (CD9) (AA 112-195) antibody
CD9 Reaktivität: Human FACS, WB, IHC, ELISA, IF Wirt: Maus Monoclonal 1E8H1 unconjugated
anti-CD9 (CD9) (AA 112-195) antibodyCD9 Reaktivität: Human WB, IHC, ELISA Wirt: Maus Monoclonal 5A6D8 unconjugated
anti-CD9 (CD9) antibodyCD9 Reaktivität: Human FACS, WB, IHC, ELISA Wirt: Maus Monoclonal 5G6 unconjugated
anti-CD9 (CD9) antibodyCD9 Reaktivität: Human IHC, StM, ISt Wirt: Maus Monoclonal CD9-2343 unconjugated
anti-CD9 (CD9) antibodyCD9 Reaktivität: Human IHC, StM Wirt: Maus Monoclonal CD9-1619 unconjugated
anti-CD9 (CD9) (Internal Region) antibodyCD9 Reaktivität: Human, Maus, Ratte WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-CD9 (CD9) antibody (Biotin)CD9 Reaktivität: Maus FACS, WB, IP, ICC Wirt: Ratte Monoclonal EM-04 Biotin
anti-CD9 (CD9) antibodyCD9 Reaktivität: Human FACS, WB, IHC (p), CyTOF Wirt: Maus Monoclonal MEM-61 unconjugated
anti-CD9 (CD9) (AA 101-200) antibodyCD9 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Schwein FACS, WB, ELISA, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-CD9 (CD9) (AA 115-145) antibodyCD9 Reaktivität: Human FACS, WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
- Applications: FC - Quality tested , IHC-FS - Reported in literature , ICC - Reported in literature , IP - Reported in literature , WB - Reported in literature
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 1 g/106 cells FITC and PE conjugates 10 L/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
- Kommentare
-
platelet inhibition and aggregation studies
- Probenmenge
- 1 mL
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.1 mg/mL
- Buffer
- 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
- Konservierungsmittel
- Without preservative
- Handhabung
- Each reagent is stable for the period shown on the bottle label if stored as directed.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store at 2-8°C
-
-
: "Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." in: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
-
: "Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy." in: Biochemical and biophysical research communications, Vol. 413, Issue 1, pp. 128-35, (2011) (PubMed).
-
- Target
- CD9
- Andere Bezeichnung
- CD9 (CD9 Produkte)
- Hintergrund
- CD9 is a 24 kDa member of the transmembrane 4 superfamily (TM4-SF) of cell surface receptors. It is expressed strongly on platelets, lymphoid progenitor cells, activated lymphocytes and endothelia, and, weakly, on eosinophils, granulocytes, monocytes, and macrophages. CD9 functions as an adhesion molecule where it mediates platelet aggregation and activation.
- Pathways
- Response to Water Deprivation, Cell-Cell Junction Organization
-
